CAI FY 2011 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$126M+61.4% YoY

Gross Profit

$120M95.6% margin

Operating Income

$64M51.1% margin

Net Income

$50M39.9% margin

EPS (Diluted)

$2.55

Cash Flow

Operating Cash Flow

$72M

Free Cash Flow

-$420M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$953M

Total Liabilities

$705M

Stockholders' Equity

$230M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$126M	$78M	+61.4%
Gross Profit	$120M	$72M	+67.6%
Operating Income	$64M	$37M	+73.9%
Net Income	$50M	$28M	+76.8%